GAS5 and central nervous system cancer: Further analysis indicated that overexpression of GAS5 in GSCs substantially diminished the expression of stem cell markers, including CD133 and Notch1, which are related to the stemness and malignant progression of gliomas (Figure 3B and Supplementary Figure 2D).